Lyon: MGM China (02282) rated as "outperform the market" with a target price of HK$11.9.
Lyon believes that MGM has a strong balance sheet and strong ability to generate regular cash flows.
Lyon released a research report stating that MGM CHINA (02282) has been rated as "outperform the market", believing that MGM has a solid balance sheet and strong ability to generate recurring cash flow. The target price is 11.9 Hong Kong dollars.
The report also mentioned that MGM CHINA's property EBITDA in the fourth quarter of last year increased by 7% to 2.126 billion yuan, exceeding market and the bank's expectations by about 4% to 5%. The market share of gaming revenue remained stable at 15.5%, and the EBITDA profit margin slightly decreased by 0.5 percentage points to 26.8%.
Related Articles
Shanghai Kehua Bio-engineering (002022.SZ) has obtained a medical device registration certificate for one of its products.
Shanghai Pharmaceuticals Holding(601607.SH): Nicorandil tablets pass consistency evaluation.
HK Stock Market Move | PC Partner (01263) fell by nearly 6% at the close of trading. The company is planning to delist from the Hong Kong Stock Exchange and change its main listing location to the Singapore Exchange.
Shanghai Kehua Bio-engineering (002022.SZ) has obtained a medical device registration certificate for one of its products.
Shanghai Pharmaceuticals Holding(601607.SH): Nicorandil tablets pass consistency evaluation.
HK Stock Market Move | PC Partner (01263) fell by nearly 6% at the close of trading. The company is planning to delist from the Hong Kong Stock Exchange and change its main listing location to the Singapore Exchange.
